Application Nr Approved Date Route Status External Links
ANDA202051 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Adefovir Dipivoxil Tablets Are Indicated For The Treatment Of Chronic Hepatitis B In Patients 12 Years Of Age And Older With Evidence Of Active Viral Replication And Either Evidence Of Persistent Elevations In Serum Aminotransferases (alt Or Ast) Or Histologically Active Disease. This Indication Is Based On Histological, Virological, Biochemical, And Serological Responses In Adult Patients With Hbeag+ And Hbeag- Chronic Hepatitis B With Compensated Liver Function, And With Clinical Evidence Of Lamivudine-Resistant Hepatitis B Virus With Either Compensated Or Decompensated Liver Function. For Patients 12 To Less Than 18 Years Of Age, The Indication Is Based On Virological And Biochemical Responses In Patients With Hbeag+ Chronic Hepatitis B Virus Infection With Compensated Liver Function. Adefovir Dipivoxil Tablets Is A Nucleotide Analogue Indicated For The Treatment Of Chronic Hepatitis B In Patients 12 Years Of Age And Older. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Adefovir Dipivoxil

Comments